Pleural infection: changing bacteriology and its implications. (Q37850473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

review article

1 reference

title

Pleural infection: changing bacteriology and its implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Grant W Waterer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Thiago Lisboa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

1 reference

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

598-603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382129%20AND%20SRC:MED&resulttype=core&format=json

Empyema thoracis: new insights into an old disease.

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

The epidemiology of hospitalized children with pneumococcal/lobar pneumonia and empyema from 1997 to 2004 in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Empyema: an increasing concern in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Trends in pneumonia and empyema in Scottish children in the past 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

U.K. Controlled trial of intrapleural streptokinase for pleural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Parapneumonic empyema deaths during past century, Utah.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

The bacteriology of pleural infection by genetic and standard methods and its mortality significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Thoracic Empyema in Patients with Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Community acquired parapneumonic thoracic empyema: predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Primary Streptococcus viridans pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

A mechanism of pathogenicity of "Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Empyema: the use of broad range 16S rDNA PCR for pathogen detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Clinical features, aetiology and outcome of empyema in children in the north east of England

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Medical management of parapneumonic pleural disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Complicated parapneumonic effusion in Belgian children: increased occurrence before routine pneumococcal vaccine implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X

Effect of Community‐Wide Conjugate Pneumococcal Vaccine Use in Infancy on Nasopharyngeal Carriage through 3 Years of Age: A Cross‐Sectional Study in a High‐Risk Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.01964.X